BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 32518661)

  • 1. Gut microbiome composition and risk factors in a large cross-sectional IBS cohort.
    Agnello M; Carroll LN; Imam N; Pino R; Palmer C; Varas I; Greene C; Hitschfeld M; Gupta S; Almonacid DE; Hoaglin MC
    BMJ Open Gastroenterol; 2020; 7(1):e000345. PubMed ID: 32518661
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characteristic dysbiosis of gut microbiota of Chinese patients with diarrhea-predominant irritable bowel syndrome by an insight into the pan-microbiome.
    Wang Z; Xu CM; Liu YX; Wang XQ; Zhang L; Li M; Zhu SW; Xie ZJ; Wang PH; Duan LP; Zhu HQ
    Chin Med J (Engl); 2019 Apr; 132(8):889-904. PubMed ID: 30958430
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gut fungal dysbiosis and altered bacterial-fungal interaction in patients with diarrhea-predominant irritable bowel syndrome: An explorative study.
    Hong G; Li Y; Yang M; Li G; Qian W; Xiong H; Bai T; Song J; Zhang L; Hou X
    Neurogastroenterol Motil; 2020 Nov; 32(11):e13891. PubMed ID: 32449259
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gut Bacterial Dysbiosis in Irritable Bowel Syndrome: a Case-Control Study and a Cross-Cohort Analysis Using Publicly Available Data Sets.
    Kim GH; Lee K; Shim JO
    Microbiol Spectr; 2023 Feb; 11(1):e0212522. PubMed ID: 36652592
    [TBL] [Abstract][Full Text] [Related]  

  • 5. No distinct microbiome signature of irritable bowel syndrome found in a Swedish random population.
    Hugerth LW; Andreasson A; Talley NJ; Forsberg AM; Kjellström L; Schmidt PT; Agreus L; Engstrand L
    Gut; 2020 Jun; 69(6):1076-1084. PubMed ID: 31601615
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gut Microbial Dysbiosis in the Irritable Bowel Syndrome: A Systematic Review and Meta-Analysis of Case-Control Studies.
    Wang L; Alammar N; Singh R; Nanavati J; Song Y; Chaudhary R; Mullin GE
    J Acad Nutr Diet; 2020 Apr; 120(4):565-586. PubMed ID: 31473156
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Involvement of shared mucosal-associated microbiota in the duodenum and rectum in diarrhea-predominant irritable bowel syndrome.
    Li G; Yang M; Jin Y; Li Y; Qian W; Xiong H; Song J; Hou X
    J Gastroenterol Hepatol; 2018 Jun; 33(6):1220-1226. PubMed ID: 29194775
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differences in gut microbial composition correlate with regional brain volumes in irritable bowel syndrome.
    Labus JS; Hollister EB; Jacobs J; Kirbach K; Oezguen N; Gupta A; Acosta J; Luna RA; Aagaard K; Versalovic J; Savidge T; Hsiao E; Tillisch K; Mayer EA
    Microbiome; 2017 May; 5(1):49. PubMed ID: 28457228
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibiotics, gut microbiota, and irritable bowel syndrome: What are the relations?
    Mamieva Z; Poluektova E; Svistushkin V; Sobolev V; Shifrin O; Guarner F; Ivashkin V
    World J Gastroenterol; 2022 Mar; 28(12):1204-1219. PubMed ID: 35431513
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular characterization of the intestinal microbiota in patients with and without abdominal bloating.
    Ringel-Kulka T; Benson AK; Carroll IM; Kim J; Legge RM; Ringel Y
    Am J Physiol Gastrointest Liver Physiol; 2016 Mar; 310(6):G417-26. PubMed ID: 26702134
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibiotics: a risk factor for irritable bowel syndrome in a population-based cohort.
    Krogsgaard LR; Engsbro AL; Bytzer P
    Scand J Gastroenterol; 2018 Sep; 53(9):1027-1030. PubMed ID: 30189148
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of Gut Microbiota and Metabolites Signature in Patients With Irritable Bowel Syndrome.
    Zhu S; Liu S; Li H; Zhang Z; Zhang Q; Chen L; Zhao Y; Chen Y; Gu J; Min L; Zhang S
    Front Cell Infect Microbiol; 2019; 9():346. PubMed ID: 31681624
    [No Abstract]   [Full Text] [Related]  

  • 13. Exploring the Role of Vitamin D and the Gut Microbiome: A Cross-Sectional Study of Individuals with Irritable Bowel Syndrome and Healthy Controls.
    Matthews SW; Plantinga A; Burr R; Cain KC; Savidge T; Kamp K; Heitkemper MM
    Biol Res Nurs; 2023 Jul; 25(3):436-443. PubMed ID: 36624571
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alternation of the gut microbiota in irritable bowel syndrome: an integrated analysis based on multicenter amplicon sequencing data.
    Chen H; Ou R; Tang N; Su W; Yang R; Yu X; Zhang G; Jiao J; Zhou X
    J Transl Med; 2023 Feb; 21(1):117. PubMed ID: 36774467
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metatranscriptome analysis of blood in healthy individuals and irritable bowel syndrome patients.
    Jagare L; Rozenberga M; Silamikelis I; Ansone L; Elbere I; Briviba M; Megnis K; Konrade I; Birka I; Straume Z; Klovins J
    J Med Microbiol; 2023 Jun; 72(6):. PubMed ID: 37335601
    [No Abstract]   [Full Text] [Related]  

  • 16. Stool and urine trefoil factor 3 levels: associations with symptoms, intestinal permeability, and microbial diversity in irritable bowel syndrome.
    Heitkemper MM; Cain KC; Shulman RJ; Burr RL; Ko C; Hollister EB; Callen N; Zia J; Han CJ; Jarrett ME
    Benef Microbes; 2018 Apr; 9(3):345-355. PubMed ID: 29633639
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of an Intestinal Microbiota Signature Associated With Severity of Irritable Bowel Syndrome.
    Tap J; Derrien M; Törnblom H; Brazeilles R; Cools-Portier S; Doré J; Störsrud S; Le Nevé B; Öhman L; Simrén M
    Gastroenterology; 2017 Jan; 152(1):111-123.e8. PubMed ID: 27725146
    [TBL] [Abstract][Full Text] [Related]  

  • 18. No Significant Association Between the Fecal Microbiome and the Presence of Irritable Bowel Syndrome-type Symptoms in Patients with Quiescent Inflammatory Bowel Disease.
    Shutkever O; Gracie DJ; Young C; Wood HM; Taylor M; John Hamlin P; Ford AC; Quirke P
    Inflamm Bowel Dis; 2018 Jun; 24(7):1597-1605. PubMed ID: 29668957
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An Open-Labeled Study on Fecal Microbiota Transfer in Irritable Bowel Syndrome Patients Reveals Improvement in Abdominal Pain Associated with the Relative Abundance of Akkermansia Muciniphila.
    Cruz-Aguliar RM; Wantia N; Clavel T; Vehreschild MJGT; Buch T; Bajbouj M; Haller D; Busch D; Schmid RM; Stein-Thoeringer CK
    Digestion; 2019; 100(2):127-138. PubMed ID: 30423561
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gut microbiome signatures reflect different subtypes of irritable bowel syndrome.
    Su Q; Tun HM; Liu Q; Yeoh YK; Mak JWY; Chan FK; Ng SC
    Gut Microbes; 2023; 15(1):2157697. PubMed ID: 36573834
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.